首页> 中文期刊> 《中国医院用药评价与分析》 >2012-2014年大理市第一人民医院麻醉药品及第一类精神药品应用分析

2012-2014年大理市第一人民医院麻醉药品及第一类精神药品应用分析

         

摘要

OBJECTIVE:To analyze the application of narcotics and the psychotropic drugs of category I in the First People's Hospital of Dali ( hereinafter referred to as “our hospital”) during 2012-2014, to improve the management level of pharmaceutical affairs so as to promote clinical rational use of drugs .METHODS: The related data about narcotics and the psychotropic drugs of category I during 2012-2014 were retrieved from the hospital information management system , the consumption amount , consumption sum and DDDs were statistically analyzed . RESULTS:The consumption amount of narcotics and the psychotropic drugs of category I had been increasing yearly , which had no changes in the proportion of the total amount of medication .The consumption amount of fentanyl injection dominated the first place; the total amount of pethidine in two specifications ranked the second; the consumption amount and sum of Morphine sustained-release tablets showed a tendency of rising;morphine injection and remifentanil had smaller consumption amount;the consumption amount of bucinnazine , codeine and ephedrine had been decreasing yearly; and there were little changes in the consumption amount of ketamine .CONCLUSIONS: The application of narcotics and the psychotropic drugs of category I in our hospital is basically rational .However, it is necessary to train the medical staff on a regular basis and constantly update their medication knowledge , which would make the application of narcotics and the psychotropic drugs of category I in our hospital become safer and more rational .%目的:分析大理市第一人民医院(以下简称“我院”)2012—2014年麻醉药品及第一类精神药品应用情况,提高我院药事管理水平,促进临床合理用药。方法:调取医院信息管理系统中2012—2014年的麻醉药品及第一类精神药品的相关数据,对其使用量、销售金额、用药频度进行分析。结果:麻醉药品和第一类精神药品的使用量逐年上升,占总销售金额比例变化不大。枸橼酸芬太尼注射液使用量居首位;哌替啶两个规格的合计使用量排第2位;吗啡缓释片的使用量及用药金额呈上升趋势;吗啡注射液及瑞芬太尼的用量较小;布桂嗪、可待因、麻黄碱使用量逐年下降;氯胺酮的使用量变化不大。结论:我院麻醉药品、第一类精神药品的使用基本合理。但应定期对医务人员进行培训,不断更新用药知识,使麻醉药品和第一类精神药品的应用更趋于安全、合理。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号